Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells

다국어 초록 (Multilingual Abstract)

Background: Deoxyelephantopin (DOE) is a natural bioactive sesquiterpene lactone from Elephantopus scaber, a traditionally relevant herb in Chinese and Indian medicine. It has shown promising anticancer effects against a broad spectrum of cancers.
Methods: We examined the effect of DOE on growth, autophagy, apoptosis, cell cycle progression, metastasis, and various molecular signaling pathways in cancer cells, and endeavored to decipher the molecular mechanisms underlying its effect. The cytotoxicity of DOE was examined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) and colony formation assays. The antimetastatic potential of DOE was identified by wound closure, as well as invasion and migration assays. The expression of mRNAs and proteins related to cytotoxicity in cancer cells induced by DOE was investigated using reverse transcription-polymerase chain reaction, flow cytometry, and Western blot analysis.
Results: DOE showed significant cytotoxicity and induced apoptosis in cancer cells. DOE promoted the autophagy of HCT 116 and K562 cells. DOE arrested cell cycle progression in the G2/M phase. DOE treatment caused activation of caspase-8, -9, -3 and -7, reactive oxygen species production, and cleavage of cleavage of poly-ADP-ribose polymerase (PARP), the markers of apoptosis. Moreover, apoptosis induction was associated with mitochondrial permeability and endoplasmic reticulum stress. Treatment of cancer cells with DOE inhibited mitogen-activated protein kinases, nuclear factor-kappa B, phosphatidylinositol 3-kinase (PI3K/Akt), and β-catenin signaling. Furthermore, treatment of DOE increased the expression of p53, phospho-Jun amino-terminal kinases (p-JNK), and p-p38 and decreased the expression of phospho-signal transducer and activator of transcription 3 (p-STAT3) and phospho-mammalian target of rapamycin (p-mTOR) in cancer cells. DOE downregulated matrix metalloproteinase (MMP-2) and MMP-9, urokinase-type plasminogen activator (uPA), and urokinase-type plasminogen activator receptor (uPAR) mRNA levels in cancer cells.
Conclusion: These findings concluded that DOE may be useful as a chemotherapeutic agent against cancer.

참고문헌 (Reference)

1 McNamee LM, "p53-independent apoptosislimits DNA damage-induced aneuploidy" 182 : 423-435, 2009

2 Muller M, "p53 activates the CD95 (APO-1/Fas) gene inresponse to DNA damage by anticancer drugs" 188 : 2033-2045, 1998

3 Guillot C, "p21WAF1/CIPresponse to genotoxic agents in wildtype TP53 expression breast primary tumours" 14 : 45-52, 199

4 Singh SDJ, "Wound healing activity of the leafextracts and deoxyelephantopin isolated from Elephantopusscaber Linn" 37 : 238-242, 2005

5 Luu HH, "Wnt/ -catenin signaling pathway as novel cancer drugtargets" 4 : 653-671, 2004

6 Smalley MJ, "Wnt signaling and mammarytumourigenesis" 6 : 37-52, 2001

7 Abraham RT, "The mammalian target ofrapamycin signaling pathway: twists and turns in the roadto cancer therapy" 13 : 3109-3114, 2007

8 Tan HK, "The mTOR signalling pathway incancer and the potential mTOR inhibitory activities ofnatural phytochemicals" 15 : 6463-6475, 2014

9 Roy N, "The c-IAP-1 and c-IAP-2 proteins are direct inhibitorsof specific caspases" 16 : 6914-6925, 1997

10 Adams JM, "The Bcl-2 apoptotic switch in cancerdevelopment and therapy" 26 : 1324-1337, 2007

11 Dalby KN, "Targeting the pro-death and pro-survival functions ofautophagy as novel therapeutic strategies in cancer" 6 : 322-329, 2010

12 Kaufmann SH, "Specific proteolytic cleavage of poly(ADP-ribose)polymerase: an early marker of chemotherapy-inducedapoptosis" 53 : 3976-3985, 1993

13 Geetha BS, "Sesquiterpenelactones isolated from Elephantopus scaber L. inhibits humanlymphocyte proliferation and the growth of tumour celllines and induces apoptosis in vitro" 2012 : 721285-, 2012

14 Bowman T, "STATs in oncogenesis" 19 : 2474-2488, 2000

15 Taylor WR, "Regulation of the G2/M transition byp53" 20 : 1803-1815, 2001

16 Rubinsztein DC, "Potential therapeutic applications of autophagy" 6 : 304-312, 2007

17 Allan LA, "Phosphorylation of caspase-9 byCDK1/cyclin B1 protects mitotic cells against apoptosis" 26 : 301-310, 2007

18 Junttila MR, "Phosphatase-mediatedcrosstalk between MAPK signaling pathways in theregulation of cell survival" 22 : 954-965, 2008

19 Amin AR, "Perspectives forcancer prevention with natural compounds" 27 : 2712-2725, 2009

20 Garg A, "Nuclear transcription factor-kB as atarget for cancer drug development" 16 : 1053-1068, 2002

21 Hong SJ, "Nuclear andmitochondrial conversations in cell death: PARP-1 and AIFsignaling" 25 : 259-264, 2004

22 Zhang R, "Morin(2',3,4',5,7-pentahydroxyflavone) protected cells againstc-radiation-induced oxidative stress" 108 : 63-72, 2010

23 Aggarwal BB, "Molecular targets of dietaryagents for prevention and therapy of cancer" 71 : 1397-1421, 2006

24 Mahoney SD, "Investigating the cytotoxic effects of the isoflavone,phenoxodiol, on prostate cancer cells" University of Western Australia 2012

25 Griffith TS, "Intracellular regulation of TRAIL-induced apoptosis inhuman melanoma cells" 161 : 2833-2840, 1998

26 Tabas I, "Integrating the mechanisms of apoptosisinduced by endoplasmic reticulum stress" 13 : 184-190, 2011

27 Carvalho AA, "Inhibition of metastatic potential ofB16-F10 melanoma cell line in vivo and in vitro by biflorin" 93 : 201-207, 2013

28 Lu H, "Inflammation, a key event incancer development" 4 : 221-233, 2006

29 Huang CC, "Hepatoprotective effect and mechanistic insights ofdeoxyelephantopin, a phyto-sesquiterpene lactone, againstfulminant hepatitis" 24 : 516-530, 2013

30 Adriaenssens E, "Growth signaling in breast cancer cells:outcomes and promises of proteomics" 64 : 797-803, 2002

31 Leist M, "Four deaths and a funeral: from caspasesto alternative mechanisms" 2 : 589-598, 2001

32 Liu Z, "Evaluationof a curcumin analog as an anti-cancer agent inducing ERstress-mediated apoptosis in non-small cell lung cancercells" 13 : 494-, 2013

33 Wan Nor Hafiza WAG, "Endoplasmic reticulum stress-inducedapoptotic pathway and mitochondrial dysregulation in HeLacells treated with dichloromethane extract of Dilleniasuffruticosa" 12 : S86-S95, 2016

34 Bertolotti A, "Dynamic interaction of BiP and ER stress transducers in theunfolded-protein response" 2 : 326-332, 2000

35 Schweinitz A, "Design of novel and selective inhibitorsof urokinase-type plasminogen activator with improvedpharmacokinetic properties for use as antimetastaticagents" 279 : 33613-33622, 2004

36 Huang CC, "Deoxyelephantopin, anovel multifunctional agent, suppresses mammary tumourgrowth and lung metastasis and doubles survival time inmice" 159 : 856-871, 2010

37 Farha AK, "Deoxyelephantopin impairs growth of cervicalcarcinoma SiHa cells and induces apoptosis by targetingmultiple molecular signaling pathways" 30 : 331-343, 2014

38 Su M, "Deoxyelephantopin from Elephantopusscaber L. induces apoptosis in the human nasopharyngeal cancer CNE cells" 411 : 342-347, 2011

39 Ricci MS, "Chemotherapeutic approaches fortargeting cell death pathways" 11 : 342-357, 2006

40 Jemal A, "Cancerstatistics 2007" 57 : 43-66, 2007

41 Zahari Z, "Bioassay-guided isolation of a sesquiterpene lactone ofdeoxyelephantopin from Elephantopus scaber Linn active onTrypanosome brucei rhodesience" 21 : 282-285, 2014

42 Choi YH, "Apoptosis induction of U937 humanleukemia cells by diallyl trisulfide induces throughgeneration of reactive oxygen species" 19 : 50-, 2012

43 Kabeer FA, "Antineoplastic effects of deoxyelephantopin, asesquiterpene lactone from Elephantopus scaber, on lungadenocarcinoma (A549) cells" 11 : 269-277, 2013

44 Xu G, "Anti-tumouractivities of the four sesquiterpene lactones fromElephantopus scaber L" 28 : 106-109, 2006

45 Farha AK, "Anti-metastatic effect of deoxyelephantopin fromElephantopus scaber in A549 lung cancer cells in vitro" 17 : 1-5, 2015

46 Zhang S, "Anti-cancer potentialof sesquiterpene lactones: bioactivity and molecularmechanisms" 5 : 239-249, 2005

47 Lin A, "Activation of the JNK signaling pathway: breaking thebrake on apoptosis" 25 : 17-24, 2003

48 Wang J, "Aberrantexpression of Beclin-1 and LC3 correlates with poorprognosis of human hypopharyngeal squamous cellcarcinoma" 8 : e69038-, 2013